Teenage patient receives treatment for papillary thyroid cancer

After a 10 hour surgery and radioactive iodine treatment, Gavin Hewitt continues pursuing his hockey dreams

3:17 PM

Author | Ananya Sen

hockey player with doctor on right holding pink and purple jersey
Gavin Hewitt and Arul Thirumoorthi at the Clash for a Cause game. Credit: Lisa sutton

Gavin Hewitt, now 18, has been playing hockey since he was four years old, and his family was used to seeing him deal with minor injuries from the sport.

In 2025, when Gavin developed a small lump on the left side of his neck, his parents assumed that it was due to swollen lymph nodes, a common sign of infection.

Gavin continued playing hockey and remained active and healthy.

When the lump persisted for a few months, his parents took him to their local hospital.

A neck ultrasound revealed that the lump could be a cancerous mass.

"We started the day thinking that our kid had nothing wrong with him and then found out he had cancer,” said Bryan Hewitt.

“We were all numb and Gavin was terrified when we heard the results.”

Gavin was immediately referred to C.S. Mott Children's Hospital at University of Michigan Health for further evaluation and treatment.

A fine-needle aspiration test, which is used to sample cells from lumps, confirmed that Gavin had papillary thyroid cancer.

Although thyroid cancer is relatively uncommon in teenagers, the rates have been rising sharply for the last 25 years.

Papillary thyroid cancer is now the second-most common cancer in teenagers, affecting appoximately 2 patients per 100,000 between ages 15 to 19.

In 40% of patients, the tumor spreads to other parts of the body.

“Gavin had extensive metastasis, where the tumor had spread to his lymph nodes,” said Arul Thirumoorthi, M.D., Clinical Associate Professor of Pediatric Surgery who led Gavin’s treatment.

“Fortunately, we have seen 95-98% survival rates with the appropriate treatment."

Ten-hour surgery and radioactive iodine treatment

Just two weeks after his diagnosis, Gavin underwent a ten-hour surgery led by Thirumoorthi and Sean Edwards, M.D., James Hayward Endowed Clinical Professor of Oral and Maxillofacial Surgery.

The surgical team removed Gavin’s thyroid and the cancer-affected lymph nodes that had spread from both sides of his neck into his chest and around his vocal cords.

A week after his surgery, Gavin underwent radioactive iodine treatment to treat any remaining cancer cells in his neck.

“Our experience at Mott was bittersweet. Even though the pediatric cancer floor is one of the saddest places, it is also one of the most hopeful,” Hewitt said.

“We were grateful for everybody on that floor who did everything they could to take care of our son.”

During his recovery, Gavin developed postoperative hypocalcemia, a condition where the body has low calcium levels after thyroid surgery.

Although he continues to take medication to maintain his calcium levels, Gavin has resumed the schedule he had before his diagnosis.

Returning to hockey after cancer treatment

Gavin currently works two jobs as a grocery store clerk and a technical assistant at a veterinary clinic. He has also resumed playing hockey.

He additionally participated in Clash for a Cause, a benefit game to raise money for cancer patients.

For the game, he wore a jersey with Thirumoorthi’s name, and together they dropped the puck for the opening face-off.

“When we manage this disease, we aim to go from a scary diagnosis to treating it like a chronic condition where the patient remains on maintenance therapy,” Thirumoorthi said.

“I'm very proud of Gavin for not letting his experience stop him from pursuing his goals.”

Learn about getting involved at BlockOutCancer.org and be a part of bringing hope, healing and brighter tomorrows to children and families facing cancer.

Sign up for Health Lab newsletters today. Get medical tips from top experts and learn about new scientific discoveries every week.

Sign up for the Health Lab Podcast. Add us wherever you listen to your favorite shows.  


More Articles About:

Thyroid Cancer Thyroid Diseases Cancer (Oncology) teens Children's Health C.S. Mott Children’s Hospital
Health Lab word mark overlaying blue cells

Health Lab

Explore thousands of health news & research stories by visiting the Health Lab homepage for more.

Media Contact

University Hospital at U-M Health in the spring with flowering trees in foreground and Survival Flight helicopter visible

Public Relations

Department of Communication at Michigan Medicine

[email protected]

734-764-2220

In This Story

proifle-arul-thirumoorthi-2017

Arul S Thirumoorthi, MD PE FACS FAAP

Clinical Associate Professor

Related

graphic of inside of a person's throat lit up orange and red
Health Lab

New guidelines issued for treating thyroid cancer

The American Thyroid Association first published guidelines for managing differentiated thyroid cancer in 1996. The current updates consider every aspect of the patient’s journey, including diagnosis, monitoring and treatment. Megan Haymart answers questions about understanding the risk for thyroid cancer, active surveillance and current treatment options.
thyroid light purple cells floating dark purple blue green faded out background
Health Lab

A ‘transformational time’ for thyroid cancer

For thyroid cancer, experts examine the current state of overdiagnosis, new therapies, health equity concerns and more.

Stay Informed

Want top health & research news weekly? Sign up for Health Lab’s newsletters today!

Subscribe

Featured News & Stories

Health Lab

4 ways to teach your teen safe driving habits

New motorists cause a disproportionate number of distracted driving accidents. That’s why laying the groundwork for safe habits must begin before your teen gets the keys.
Portrait of Peter Mourani, M.D., Professor and Associate Chair of Research for the Department of Pediatrics and Division Director of Pediatric Critical Care Medicine at Michigan Medicine and U-M Health C.S. Mott Children's Hospital.
News Release

U-M-led consortium to receive up to $52 million in NIH funding to study why viral respiratory infections affect children differently

A Michigan Medicine-led research consortium has secured approval for up to $52 million in federal funding to launch a multicenter study examining why some young children recover fully from viral lower respiratory tract infections while others develop severe illness or lasting problems such as asthma.
pattern up close sequencing gene navy yellow
Health Lab

Comprehensive DNA sequencing reveals hidden drivers of cancer

Two research papers describe how long-read nanopore sequencing can detect alterations in cancer cells that might be missed by conventional sequencing.
cancer cell blue yellow
Health Lab

‘Molecular glue’ stabilizes protein that inhibits development of non-small cell lung cancer and uterine cancer

University of Michigan researchers found a new protein target PP2A and developed a drug to treat non-small cell lung cancers that have KRAS mutations.
chart with sonogram images woman pregnant in background
Health Lab

Better prenatal care data could help prevent maternal complications, experts say

Changes to prenatal care billing and quality reporting could help reshape how prenatal care is measured and improve the ability to address risks before they become emergencies per a Michigan Medicine-led commentary in Obstetrics & Gynecology, The Green Journal.
red blood cells going through clear tube red background
Health Lab

FDA-approved drug offers hope for patients with polycythemia vera, a rare bone marrow disorder

FDA-approved rusfertide offers new hope for polycythemia vera patients by reducing phlebotomy dependence, easing symptoms, and improving daily life.